X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Sun Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS SUN PHARMA DR. DATSONS LABS/
SUN PHARMA
 
P/E (TTM) x -10.9 15.3 - View Chart
P/BV x 0.2 3.6 4.5% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 DR. DATSONS LABS   SUN PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
SUN PHARMA
Mar-16
DR. DATSONS LABS/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,201 10.5%   
Low Rs31706 4.4%   
Sales per share (Unadj.) Rs133.0117.5 113.2%  
Earnings per share (Unadj.) Rs0.219.6 0.8%  
Cash flow per share (Unadj.) Rs6.623.8 27.8%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.1 0.0%  
Book value per share (Unadj.) Rs128.8130.5 98.7%  
Shares outstanding (eoy) m31.662,406.60 1.3%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.68.1 7.2%   
Avg P/E ratio x516.148.7 1,060.7%  
P/CF ratio (eoy) x11.840.1 29.6%  
Price / Book Value ratio x0.67.3 8.3%  
Dividend payout %05.1 0.0%   
Avg Mkt Cap Rs m2,4772,294,813 0.1%   
No. of employees `000NA14.7 0.0%   
Total wages/salary Rs m5647,971 0.1%   
Avg. sales/employee Rs ThNM19,169.8-  
Avg. wages/employee Rs ThNM3,253.0-  
Avg. net profit/employee Rs ThNM3,197.9-  
INCOME DATA
Net Sales Rs m4,211282,697 1.5%  
Other income Rs m796,170 1.3%   
Total revenues Rs m4,289288,867 1.5%   
Gross profit Rs m56983,239 0.7%  
Depreciation Rs m20410,135 2.0%   
Interest Rs m4304,769 9.0%   
Profit before tax Rs m1374,505 0.0%   
Minority Interest Rs m0-11,126 0.0%   
Prior Period Items Rs m-2-19 9.6%   
Extraordinary Inc (Exp) Rs m0-6,852 0.0%   
Tax Rs m69,349 0.1%   
Profit after tax Rs m547,159 0.0%  
Gross profit margin %13.529.4 45.9%  
Effective tax rate %48.012.5 382.8%   
Net profit margin %0.116.7 0.7%  
BALANCE SHEET DATA
Current assets Rs m6,852308,646 2.2%   
Current liabilities Rs m6,711132,477 5.1%   
Net working cap to sales %3.362.3 5.4%  
Current ratio x1.02.3 43.8%  
Inventory Days Days16183 193.9%  
Debtors Days Days31888 363.0%  
Net fixed assets Rs m3,673133,606 2.7%   
Share capital Rs m3172,407 13.2%   
"Free" reserves Rs m3,761266,909 1.4%   
Net worth Rs m4,078314,042 1.3%   
Long term debt Rs m1,67131,167 5.4%   
Total assets Rs m12,633542,196 2.3%  
Interest coverage x1.016.6 6.2%   
Debt to equity ratio x0.40.1 412.9%  
Sales to assets ratio x0.30.5 63.9%   
Return on assets %3.49.6 36.0%  
Return on equity %0.115.0 0.8%  
Return on capital %7.717.8 43.2%  
Exports to sales %22.914.0 163.6%   
Imports to sales %14.33.1 455.0%   
Exports (fob) Rs m96439,572 2.4%   
Imports (cif) Rs m6028,882 6.8%   
Fx inflow Rs m96442,171 2.3%   
Fx outflow Rs m60721,583 2.8%   
Net fx Rs m35720,588 1.7%   
CASH FLOW
From Operations Rs m1,34567,694 2.0%  
From Investments Rs m-2,256-44,549 5.1%  
From Financial Activity Rs m-1,200-19,243 6.2%  
Net Cashflow Rs m-2,1113,902 -54.1%  

Share Holding

Indian Promoters % 4.5 63.7 7.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.1 -  
FIIs % 1.4 23.0 5.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 8.3 1,133.7%  
Shareholders   20,807 133,026 15.6%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   GSK PHARMA  JUBILANT LIFE SCIENCES  BIOCON LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS